Barbara Klencke
2019
In 2019, Barbara Klencke earned a total compensation of $971.4K as Chief Development Officer at ProNAi Therapeutics, which was about the same as previous year.
Compensation breakdown
Non-Equity Incentive Plan | $184,737 |
---|---|
Option Awards | $297,710 |
Salary | $486,150 |
Other | $2,800 |
Total | $971,397 |
Klencke received $486.2K in salary, accounting for 50% of the total pay in 2019.
Klencke also received $184.7K in non-equity incentive plan, $297.7K in option awards and $2.8K in other compensation.
Rankings
In 2019, Barbara Klencke's compensation ranked 9,399th out of 13,971 executives tracked by ExecPay. In other words, Klencke earned more than 32.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,399 | 33rd |
Manufacturing | 3,772 | 34th |
Chemicals And Allied Products | 1,432 | 35th |
Drugs | 1,221 | 35th |
Pharmaceutical Preparations | 908 | 35th |
Klencke's colleagues
We found two more compensation records of executives who worked with Barbara Klencke at ProNAi Therapeutics in 2019.